Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Report

BRAEBURN PHARMACEUTICALS

via HCM STRATEGISTS

2nd Quarter (Apr 1 - June 30) · 2018Posted Jul 21, 2018Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: BRAEBURN PHARMACEUTICALS
Description: Pharmaceutical Company
Location: New Jersey · United States of America

Registrant

Firm: HCM STRATEGISTS
Description: Health care and educational equity advocacy
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
S916 Protecting Patient Access to Emergency Medication Act of 2017
LobbyistsJUSTIN BELAND
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

BRAEBURN PHARMACEUTICALS — Lobbying — Receipts Report